Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
To assess the effect of risperidone 2 mg daily (QD) on the differential sensitivity of 2
spatial working memory tests (the GMLT and MDR) in non-agitated, drug-naive patients
suffering from first-episode schizophrenia/schizophreniform disorder.